Neurostatus-SMARTCARE clinical trial: Enabling health care professionals to assess EDSS for decentralized trials in multiple sclerosis.

Autor: Mallucci G; Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Basel, Switzerland.; Neurocenter of Southern Switzerland, Regional Hospital of Lugano, Ente Ospedaliero Cantonale (EOC), Lugano, Switzerland., Zimmer A; Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Basel, Switzerland., Sfikas N; Novartis Pharma AG, Basel, Switzerland., Cerdá-Fuertes N; Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Basel, Switzerland., Wunderlin S; Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Basel, Switzerland., Athanasopoulou I; Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Basel, Switzerland., Mroczek M; Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Basel, Switzerland., Phavanh V; Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Basel, Switzerland., Sanak L; Neurocenter, Lucerne Cantonal Hospital, Lucerne, Switzerland., Suter J; Neurocenter, Lucerne Cantonal Hospital, Lucerne, Switzerland., Friedli B; Neurocenter, Lucerne Cantonal Hospital, Lucerne, Switzerland., Kel J; Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Basel, Switzerland., Trouillet T; Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Basel, Switzerland., Simmen S; Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Basel, Switzerland., Ocampo A; Novartis Pharma AG, Basel, Switzerland., Wei W; Novartis Pharma AG, Basel, Switzerland., Kieseier B; Novartis Pharma AG, Basel, Switzerland., Kamm CP; Neurocenter, Lucerne Cantonal Hospital, Lucerne, Switzerland.; Department of Neurology, Inselspital, Bern University Hospital and University of Bern, Bern, Switzerland., Kappos L; Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Basel, Switzerland., D'Souza M; Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Basel, Switzerland.; Department of Neurology, University Hospital Basel, Basel, Switzerland.

Publikováno v: Multiple sclerosis (Houndmills, Basingstoke, England) [Mult Scler] 2024 Dec 20, pp. 13524585241305966. Date of Electronic Publication: 2024 Dec 20.

TGFβR signalling determines CD103+CD11b+ dendritic cell development in the intestine

Autor: Bain, C. C., Montgomery, J., Scott, C L, Kel, J M, Girard-Madoux, M J H, Martens, L, Zangerle-Murray, T F P, Ober-Blobaum, J, Lindenbergh-Kortleve, D, Samsom, J N, Henri, S., Lawrence, T, Saeys, Y, Malissen, B., Dalod, M., Clausen, B E, Mowat, Alan McI.

Publikováno v: Bain, C C, Montgomery, J, Scott, C L, Kel, J M, Girard-Madoux, M J H, Martens, L, Zangerle-Murray, T F P, Ober-Blobaum, J, Lindenbergh-Kortleve, D, Samsom, J N, Henri, S, Lawrence, T, Saeys, Y, Malissen, B, Dalod, M, Clausen, B E & Mowat, A M 2017, ' TGFβR signalling determines CD103 + CD11b + dendritic cell development in the intestine ', Nature Communications, vol. 8, 620 . https://doi.org/10.1038/s41467-017-00658-6

CD103+CD11b+ dendritic cells (DCs) are unique to the intestine, but the factors governing their differentiation are unclear. Here we show that transforming growth factor receptor 1 (TGFβR1) has an indispensable, cell intrinsic role in the developmen

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3094::8adc0ed4e62072b4d6d0c8d2b54a00ee
https://hdl.handle.net/20.500.11820/e49e1dac-059d-4526-b866-fbe504ef8431

TGF beta R signalling controls CD103(+)CD11b(+) dendritic cell development in the intestine

Autor: Bain, C. C., Montgomery, J., Scott, C. L., Kel, J. M., Girard-Madoux, M. J. H., Martens, L., Zangerle-Murray, T. F. P., Ober-Blobaum, J., Lindenbergh-Kortleve, D., Samsom, J. N., Henri, S., Lawrence, T., Saeys, Y., Malissen, Bernard, Dalod, M., Clausen, B. E., Mowat, A. Mcl.

Publikováno v: Nature Communications, 8:620. Nature Publishing Group
Nature Communications
Nature Communications, Nature Publishing Group, 2017, 8 (1), ⟨10.1038/s41467-017-00658-6⟩
Nature Communications, 2017, 8 (1), ⟨10.1038/s41467-017-00658-6⟩

International audience; CD103(+)CD11b(+) dendritic cells (DCs) are unique to the intestine, but the factors governing their differentiation are unclear. Here we show that transforming growth factor receptor 1 (TGF beta beta R1) has an indispensable,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::0faa70d86aa5692ac4ec9c61b74a6c9e
https://pure.eur.nl/en/publications/65905812-f826-48ab-a425-35c369bfa95e

Corporate Human Trafficking.

Autor: Chatman, Carliss^1,2,3,4

Publikováno v: Texas Law Review. May2024, Vol. 102 Issue 6, p1263-1302. 40p.

Ag co-catalyst prepared by ultrasonic reduction method for efficient photocatalytic conversion of CO2 with H2O using ZnTa2O6 photocatalyst.

Autor: Kawata, Kio, Iguchi, Shoji, Naniwa, Shimpei, Tanaka, Tsunehiro, Nishimoto, Masamu, Teramura, Kentaro

Publikováno v: Catalysis Science & Technology; 11/7/2024, Vol. 14 Issue 21, p6207-6214, 8p